NDC Package 0093-7662-56 Erlotinib

Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0093-7662-56
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Erlotinib
Non-Proprietary Name:
Erlotinib
Substance Name:
Erlotinib Hydrochloride
Usage Information:
None.
11-Digit NDC Billing Format:
00093766256
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 603203 - erlotinib 100 MG Oral Tablet
  • RxCUI: 603203 - erlotinib 100 MG (equivalent to erlotinib HCl 109.3 MG) Oral Tablet
  • RxCUI: 603206 - erlotinib 150 MG Oral Tablet
  • RxCUI: 603206 - erlotinib 150 MG (equivalent to erlotinib HCl 163.9 MG) Oral Tablet
  • RxCUI: 603208 - erlotinib 25 MG Oral Tablet
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Teva Pharmaceuticals Usa, Inc.
    Dosage Form:
    Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    ANDA091059
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    12-08-2021
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0093-7662-56?

    The NDC Packaged Code 0093-7662-56 is assigned to a package of 30 tablet, film coated in 1 bottle of Erlotinib, a human prescription drug labeled by Teva Pharmaceuticals Usa, Inc.. The product's dosage form is tablet, film coated and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

    Is NDC 0093-7662 included in the NDC Directory?

    Yes, Erlotinib with product code 0093-7662 is active and included in the NDC Directory. The product was first marketed by Teva Pharmaceuticals Usa, Inc. on December 08, 2021 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0093-7662-56?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

    What is the 11-digit format for NDC 0093-7662-56?

    The 11-digit format is 00093766256. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20093-7662-565-4-200093-7662-56